Accessibility Menu
Globus Medical logo

Globus Medical(NYSE) GMED

Market Cap$11.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+544%
5 Year+8%
1 Year+34%
1 Month+10%
Premium Feature
Moneyball Superscore
79/100
$84.12
-3.21%
-2.79Today
After hours$84.02-$0.10 (-0.12%)
Globus Medical last closing stock price
MetricPriceDate
Last closeUSD 84.082026-08-24
Globus Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.22%USD 85.122026-08-17
1 month+9.92%USD 76.492026-07-24
3 month-1.2%USD 85.102026-05-26
Year to date-3.7%USD 87.312025-12-31
1 year+34.48%USD 62.522025-08-22
3 year+53.54%USD 54.762023-08-25
5 year+8.2%USD 77.712021-08-25
Since inception+543.78%USD 13.502012-08-03

Globus Medical Financials at a Glance

Market Cap

$11.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.14B

Net Income (TTM)

$535.46M

EPS (TTM)

$3.91

P/E Ratio

21.50

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$84.12

Volume

1,132,312.327

Open

$86.92

Previous Close

$84.08

Daily Range

$83.62 - $87.27

52-Week Range

$54.15 - $101.40

Estimated Earnings Date

Nov 5, 2026

GMED: Motley Fool Moneyball Superscore

79

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Globus Medical

Globus Medical, Inc. makes tools that help doctors fix bone problems. Its products help patients recover from injuries or long-term pain. The company sells these solutions to hospitals and surgery centers.

Tools for the Operating Room

  • Musculoskeletal Solutions: Implantable devices and biologics for spinal and orthopedic procedures; includes spinal cord stimulation for chronic pain.
  • Enabling Technologies: Computer systems for robotic surgery and imaging; designed to improve implant placement accuracy.
  • Neuromonitoring Services: Software that detects nerves during surgery; used to help surgeons avoid accidental nerve damage.

Strategic Moves and Mergers

  • Acquired Nevro Corp on April 3, 2025, to add spinal cord stimulation technology to its portfolio.
  • Launched the 2025 Strategic Integration Plan to manage business transitions following the recent merger.
  • Expanded international sales reach to approximately 61 countries through a mix of direct and distributor networks.
  • Increased the U.S. sales force to strengthen its market position in domestic hospitals.

Why Globus Stands Out

The company uses an engineering-driven approach to quickly turn surgeon feedback into new medical devices. Its systems combine robotic assistance with physical implants to make complex surgeries safer for patients.

Key Figures and Results

  • Total net sales reached $789.6 million for the three-month period ended June 30, 2026, up 5.9% year over year.
  • International net sales grew to $170.5 million during the second quarter of 2026, an 18.0% increase year over year.
  • Net cash provided by operating activities was $412.1 million for the six-month period ended June 30, 2026.
  • Selling, general, and administrative expenses fell 5.5% to $286.8 million during the three-month period ended June 30, 2026.

Bottom Line

Globus Medical has transitioned from a spinal implant specialist into a broad musculoskeletal technology provider. The integration of robotics and neuromodulation assets supports its goal of improving surgical outcomes.

AI Generated • Aug 7, 2026

Industry

Healthcare Equipment and Supplies

Employees

6,000

CEO

Keith W. Pfeil, EMBA

Headquarters

Audubon, PA 19403-5214, US

GMED Financials

Key Financial Metrics (TTM)

Gross Margin

68.55%

Operating Margin

20.75%

Net Income Margin

17.03%

Return on Equity

11.59%

Return on Capital

10.23%

Return on Assets

9.76%

Earnings Yield

4.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

134.26M

Volume

1.13M

Avg. Volume

1.69M

Financials (TTM)

Gross Profit

$2.16B

Operating Income

$652.69M

EBITDA

$876.26M

Operating Cash Flow

$910.39M

Capital Expenditure

-$159.80M

Free Cash Flow

$750.59M

Cash & ST Invst.

$595.14M

Total Debt

$111.19M

Globus Medical Performance Analysis

Globus Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,022,843,0006.8%
20232023-12-31USD 1,568,476,00053.3%
20242024-12-31USD 2,519,355,00060.6%
20252025-12-31USD 2,938,931,00016.7%
Globus Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303.2%
Q42025-12-317.5%
Q12026-03-31-8.1%
Q22026-06-303.9%
Globus Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.8528.7%
20232023-12-31USD 1.07-42.1%
20242024-12-31USD 0.75-30.3%
20252025-12-31USD 3.92425.4%
Globus Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-40.9%
Q42025-12-3114.8%
Q12026-03-31-10.9%
Q22026-06-3022.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$789.61M

+5.9%

Gross Profit

$548.17M

+10.4%

Gross Margin

69.42%

N/A

Market Cap

$11.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.88M

N/A

Employees

6,000

N/A

Net Income

$151.57M

-25.3%

EBITDA

$189.82M

-1.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$595.14M

+159.4%

Total Debt

$111.19M

-8.2%

Accounts Receivable

$739.28M

+12.0%

Inventory

$810.90M

+5.0%

Long Term Debt

$96.81M

-10.3%

Short Term Debt

$14.39M

+9.2%

Return on Assets

9.76%

N/A

Return on Invested Capital

13.03%

N/A

Free Cash Flow

$176.57M

+571.3%

Operating Cash Flow

$209.74M

+169.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DVADaVita Inc.
$176.50+1.54%
ALGNAlign Technology, Inc.
$159.64-1.79%
MOHMolina Healthcare, Inc.
$198.50-0.89%
BIOBio-Rad Laboratories, Inc.
$381.76+0.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$208.48-0.03%
BITOProShares Trust - ProShares Bitcoin ETF
$10.63+0.02%
INTCIntel
$87.26-0.03%
IBITiShares Bitcoin Trust
$44.64+0.02%

Questions About GMED

What is the current price of Globus Medical?

Globus Medical is trading at $84.08 per share.

What is the 52-week range for Globus Medical?

Over the past 52 weeks, Globus Medical has traded between $54.15 and $101.40.

How much debt does Globus Medical have?

As of the most recent reporting period, Globus Medical reported total debt of $111.91M.

How much cash does Globus Medical have on hand?

Globus Medical reported $507.75M in cash and cash equivalents in its most recent financial results.

What is Globus Medical’s dividend yield?

Globus Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.